Formulation Strategies to Optimize the In Vitro Release of Fenbendazole from Immediate-Release Tablets Containing Amorphous Hydroxypropyl-β-Cyclodextrin Inclusion Complexes
Year: 2026
Type: article
Abstract: Background/Objectives: The aim of this study is to obtain new inclusion complexes of fenbendazole (FEN) with hydroxypropyl-β-cyclodextrin (HP-β-CD) in order to optimize the in vitro release profile of fenbendazole from immediate-release tablets. Methods: Inclusion complexes and solid dispersions were prepared by coprecipitation, lyophilization, and kneading at 1:0.25 and 1:0.5 (FEN:HP-β-CD) sub-stoichiometric molar ratios. Physical mixtures were prepared for comparison. Both physical mixtures and inclusion complexes were subsequently evaluated using physicochemical and pharmacotehnical methods. Results: Physicochemical analysis (FTIR, XRD, and TG/DTA) showed that lyophilization successfully induced solid-state amorphization of the drug at both ratios. Directly compressed tablets exhibited excellent mechanical properties, with crushing strength ranging from 65.1 ± 2.4 N (F3) to 87.4 ± 2.9 N (F2) and 98.2 ± 3.5 N (F1), friability below 0.7%, and rapid disintegration (58 ± 3.2 s for F1, 69 ± 4.1 s for F2, and 77 ± 4.5 s for F3). In vitro dissolution was strongly medium-dependent: at pH 1.2, cyclodextrin-based tablets achieved near-complete dissolution within 60 min (Q60 = 96.8 ± 2.1, DE% = 81.8 ± 1.9% for F1; Q60 = 99.5 ± 1.8%, DE% = 71.4 ± 2.3% for F2), compared with the uncomplexed drug (Q60 = 63.3 ± 2.4%, DE% = 47.5 ± 1.7% for F3). At pH 4.5 and 6.8, drug release plateaued below 15% and 38%, respectively, due to non-sink saturation constraints. Conclusions: This study provides in vitro proof of concept that sub-stoichiometric amorphization with HP-β-CD, coupled with direct compression, overcomes the gastric dissolution barrier of fenbendazole, establishing a solid biopharmaceutical basis for future in vivo bioavailability and stability evaluations.
Source: Pharmaceutics
Authors: Ramona-Daniela Pârvănescu(Conceptualization, Formal analysis, Investigation, Validation), Emma Adriana Ozon(Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing), Adina Magdalena Musuc(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Visualization, Writing – original draft, Writing – review & editing), Cristina-Maria Trandafirescu(Formal analysis, Investigation), Codruța Șoica(Formal analysis, Investigation), Vasile-Adrian Surdu(Formal analysis, Investigation), Veronica Bratan(Formal analysis, Investigation), Daniela C. Culita(Formal analysis, Investigation), Ancuța Cătălina Fița(Formal analysis, Investigation), Ion Mircioiu(Formal analysis, Investigation, Methodology, Writing – original draft)
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7236270898
